Xenon does not reduce opioid requirement for orthopedic surgery

Canadian Journal of Anesthesia

Volumn 52, Issue 1, 2005, Pages 38-44

  Luginbühl, Martin ^a   Petersen Felix, Steen ^a   Zbinden, Alex M ^a   Schnider, Thomas W ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; DESFLURANE; NITROUS OXIDE; XENON;

ADULT; ARTICLE; BISPECTRAL INDEX; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; GENERAL ANESTHESIA; HEART RATE; HIP DISLOCATION; HUMAN; HYPOTHESIS; INTRAOPERATIVE PERIOD; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; ORTHOPEDIC SURGERY; OSTEOTOMY; PRESSOR RESPONSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN INCISION;

EID: 14944383205     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03018578     Document Type: Article

References (34)

1. Lachmann B, Armbruster S, Schairer W, et al. Safety and efficacy of xenon in routine use as an inhalational anaesthetic. Lancet 1990; 335: 1413-5.
2. Goto T, Saito H, Shinkai M, Nakata Y, Ichinose F, Morita S Xenon provides faster emergence from anesthesia than does nitrous oxide-sevoflurane or nitrous oxide-isoflurane. Anesthesiology 1997; 86: 1273-8.
3. Hettrick DA, Pagel PS, Kersten JR, et al. Cardiovascular effects of xenon in isoflurane-anesthetized dogs with dilated cardiomyopathy. Anesthesiology 1998; 89: 1166-73.
4. Luttropp HH, Romner B, Perhag L, Eskilsson J, Fredriksen S, Werner O. Left ventricular performance and cerebral haemodynamics during xenon anaesthesia. A transoesophageal echocardiography and transcranial Doppler sonography study. Anaesthesia 1993; 48: 1045-9.
5. Lane GA, Nahrwold ML, Tait AR, Taylor-Busch M, Cohen PJ, Beaudoin AR. Anesthetics as teratogens: nitrous oxide is fetotoxic, xenon is not. Science 1980; 210: 899-901.
6. Rossaint R, Reyle-Hahn M, Schulte Am Esch J, et al. Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. Anesthesiology 2003; 98: 6-13.
7. Goto T, Nakata Y, Ishiguro Y, Niimi Y, Suwa K, Morita S Minimum alveolar concentration-awake of xenon alone and in combination with isoflurane or sevoflurane. Anesthesiology 2000; 93: 1188-93.
8. Russsell IF. Comparison of wakefulness with two anaesthetic regimens. Total i.v. v. balanced anaesthesia. Br J Anaesth 1986; 58: 965-8.
9. Rampil IJ, Lockhart SH, Zwass MS, et al. Clinical characteristics of desflurane in surgical patients: minimum alveolar concentration. Anesthesiology 1991; 74: 429-33.
10. Nickalls RW, Mapleson WW. Age-related iso-MAC charts for isoflurane, sevoflurane and desflurane in man. Br J Anaesth 2003; 91: 170-4.
11. Pocock SJ. Methods of randomization. In: Pocock SJ (Ed.). Clinical Trials. A Practical Approach. Chichester: John Wiley & Sons; 1984: 80-7.
12. Lemmens HJ, Bovill JG, Hennis PJ, Gladines MP, Burm AG. Alcohol consumption alters the pharmacodynamics of alfentanil. Anesthesiology 1989; 71: 669-74.
13. Raemer DB, Buschman A, Varvel JR, et al. The prospective use of population pharmacokinetics in a computer-driven infusion system for alfentanil. Anesthesiology 1990; 73: 66-72.
14. Iselin-Chaves IA, Flaishon R, Sebel PS, et al. The effect of the interaction of propofol and alfentanil on recall, loss of consciousness, and the bispectral index. Anesth Analg 1998; 87: 949-55.
15. Ausems ME, Hug CC Jr, Stanski DR, Burm AG. Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery. Anesthesiology 1986; 65: 362-73.
16. Luginbuhl M, Lauber R, Feigenwinter P, Zbinden AM. Monitoring xenon in the breathing circuit with a thermal conductivity sensor. Comparison with a mass spectrometer and implications on monitoring other gases. J Clin Monit Comput 2002; 17: 23-30.
17. Kingsbury DP, Makowski GS, Stone JA. Quantitative analysis of fentanyl in pharmaceutical preparations by gas chromatography-mass spectrometry. J Anal Toxicol 1995; 19: 27-30.
18. Gan TJ, Glass PS, Windsor A, et al. Bispectral index monitoring allows faster emergence and improved recovery from propofol, alfentanil, and nitrous oxide anesthesia. BIS Utility Study Group. Anesthesiology 1997; 87: 808-15.
19. Lavigne M, Parvizi J, Beck M, Siebenrock KA, Ganz R, Leunig M. Anterior femoroacetabutar impingement. Part I. Techniques of joint preserving surgery. Clin Orthop 2004; 61-6.
20. Luginbuhl M, Schnider TW. Detection of awareness with the bispectral index: two case reports. Anesthesiology 2002, 96: 241-3.
21. Rampil IJ, Mason P, Singh H. Anesthetic potency (MAC) is independent of forebrain structures in the rat. Anesthesiology 1993; 78: 707-12.
22. Doi M, Gajraj RJ, Mantzaridis H, Kenny GN. Prediction of movement at laryngeal mask airway insertion: comparison of auditory evoked potential index, bispectral index, spectral edge frequency and median frequency. Br J Anaesth 1999; 82: 203-7.
23. Rampil IJ, Kim JS, Lenhardt R, Negishi C, Sessler DI. Bispectral EEG index during nitrous oxide administration. Anesthesiology 1998; 89: 671-7.
24. Song D, Joshi GP, White PF. Titration of volatile anesthetic using bispectral index facilitates recovery after ambulatory anesthesia. Anesthesiology 1997; 87: 842-8.
25. Goto T, Nakata V, Saito H, et al. Bispectral analysis of the electroencephalogram does not predict responsiveness to verbal command in patients emerging from xenon anaesthesia. Br J Anaesth 2000; 85: 359-67.
26. Cullen SC, Eger EI II, Cullen BF, Gregory P. Observations on the anesthetic effect of the combination of xenon and halothane. Anesthesiology 1969; 31: 305-9.
27. Nakata Y, Goto T, Ishiguro Y, et al. Minimum alveolar concentration (MAC) of xenon with sevoflurane in humans. Anesthesiology 2001; 94: 611-4.
28. Gambus PL, Gregg KM, Shafer SL. Validation of the alfentanil canonical univariate parameter as a measure of opioid effect on the electroencephalogram. Anesthesiology 1995; 83: 747-56.
29. Nakata Y, Goto T, Saito H, et al. Plasma concentration of fentanyl with xenon to block somatic and hemodynamic responses to surgical incision. Anesthesiology 2000; 92: 1043-8.
30. Vuyk J, Lim T, Engbers FH, Burm AG, Vletter AA, Bovill JG Pharmacodynamics of alfentanil as a supplement to propofol or nitrous oxide for lower abdominal surgery in female patients. Anesthesiology 1993; 78: 1036-45.
31. Lathi KG, Vale PR, Losordo DW, et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease: anesthetic management and results. Anesth Analg 2001; 92: 19-25.
32. De Hert SG, Van der Linden PJ, ten Broecke PW, Vermeylen KT, Rodrigus IE, Stockman BA. Effects of desflurane and sevoflurane on length-dependent regulation of myocardial function in coronary surgery patients. Anesthesiology 2001; 95: 357-63.
33. Ma D, Wilhelm S, Maze M, Franks NP. Neuroprotective and neurotoxic properties of the 'inert' gas, xenon. Br J Anaesth 2002; 89: 739-46.
34. Ma D, Yang H, Lynch J, Franks NP, Maze M, Grocott HP. Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat. Anesthesiology 2003; 98: 690-8.